The Hebrew University of Jerusalem has announced the launch of a Multidisciplinary Center on Cannabinoid Research (http://cannabinoids.huji.ac.il). The new Center will serve as one of the world’s leading institutes for conducting and coordinating research about cannabinoids, endocannabinoids and medical Cannabis. In addition, it will promote collaboration and disseminate information.
Staffed by some of the world’s leading scientists and medical doctors from the Hebrew University and its affiliated Hadassah Medical Center, the Multidisciplinary Center is already supporting exciting new research. In February 2017, the Center awarded funding to three research projects:
- The effects of CBD on traumatic brain injury (Prof. Rami Yaka & Prof. Oren Ostresetzer)
- The anti-angiogenic and anti-cancer activity of cannabinoid receptor 2 (CB2) agonists (Dr. Ofra Benny)
- Effect of a Cannabis extract on acute radicular pain and on analgesics (Prof. Elyad Davidson)
“The establishment in Israel of the Multidisciplinary Center on Cannabinoid Research is of great relevance at this time since both academic institutions and pharmaceutical companies worldwide are channeling enormous efforts to basic and clinical research in this field,” said Dr. Joseph (Yossi) Tam, Director of the Hebrew University’s Multidisciplinary Center on Cannabinoid Research, and Head of the Obesity and Metabolism Laboratory at the Hebrew University’s Institute for Drug Research in the Faculty of Medicine.